Agomab Therapeutics NV
AGMB$541M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaANTWERPEN57 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jul 23, 2026
4wMarket Overview
Stock performance and key metrics
AGMB News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AGMB-129 | Phase 2 | Fibrostenotic Crohn's Disease | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply